IDiyas

For the Inventor, By the Inventor

Colonia, NJ, United States of America

Robert L Bugianesi

USPTO Granted Patents = 17

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 174(Granted Patents)


Location History:

  • Colonia, NJ (US) (1980 - 1999)
  • Brick, NJ (US) (2003 - 2009)

Company Filing History:

goldMedal17 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1980-2009

Loading Chart...
17 patents (USPTO):
1. 7479504 - Edg receptor agonists (2009-01-20),
2. 6528531 - Aliphatic hydroxy substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents (2003-03-04),
3. 5985892 - Antagonists of gonadotropin releasing hormone (1999-11-16),
4. 5756507 - Antagonists of gonadotropin releasing hormone (1998-05-26),
5. 5506262 - Cholesterol lowering compounds (1996-04-09),
6. 5369125 - Cholesterol-lowering agents (1994-11-29),
7. 5114961 - 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists (1992-05-19),
8. 5010100 - Certain 2,5-diaryl tetrahydrofurans and analogs thereof as PAF (1991-04-23),
9. 5001123 - 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists (1991-03-19),
10. 4996203 - 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists (1991-02-26),
11. 4761404 - Phospholipid analogs useful as PAF synthesis inhibitors (1988-08-02),
12. 4704462 - Substituted 2,3,3a,6-tetrahydro-6-oxobenzofuran derivative useful as PAF (1987-11-03),
13. 4554349 - Aralkyl and aralkenyl glycosides as inhibitors of antigen-specific (1985-11-19),
14. 4386026 - Cell-specific glycopeptide ligands (1983-05-31),
15. 4259324 - Immunologic adjuvant thio glycoside compounds and compositions (1981-03-31),

Title: The Innovative Contributions of Robert L Bugianesi

Introduction

Robert L Bugianesi is a prominent inventor based in Colonia, NJ (US), known for his significant contributions to the field of pharmaceuticals. With a total of 17 patents to his name, he has made remarkable advancements in the treatment of various medical conditions.

Latest Patents

Among his latest patents is the invention of Edg receptor agonists. This invention encompasses compounds of Formula 1, along with their pharmaceutically acceptable salts and hydrates. These compounds are particularly useful for treating immune-mediated diseases and conditions, such as bone marrow, organ, and tissue transplant rejection. Another notable patent is for aliphatic hydroxy substituted piperidyl diaryl pyrrole derivatives, which serve as antiprotozoal agents. These trisubstituted pyrroles are effective in the treatment and prevention of protozoal diseases in both humans and animals, including the control of coccidiosis in poultry.

Career Highlights

Robert L Bugianesi is currently associated with Merck & Company, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work has had a significant impact on the development of new treatments and therapies.

Collaborations

Throughout his career, Bugianesi has collaborated with notable colleagues, including Mitree M Ponpipom and Tesfaye Biftu. These collaborations have further enhanced his research and development efforts.

Conclusion

Robert L Bugianesi's innovative work and numerous patents highlight his dedication to advancing medical science. His contributions continue to play a vital role in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…